Embattled iPLEDGE Program: Changes Ahead? : vimarsana.com

The FDA announced that two FDA advisory committees will meet in March to discuss proposed changes to the embattled program to ''minimize burden on patients, pharmacies, and prescribers."

Related Keywords

Pennsylvania , United States , American , Andrea Zaenglein , Ophthalmic Drugs Advisory Committee On , American Academy Of Dermatology Association , Isotretinoin Products Manufacturers Group , Risk Management Advisory Committee , Penn State Hershey Medical Center , Drug Administration , Drug Safety , Ophthalmic Drugs Advisory Committee , American Academy , Dermatology Association , Patient Safety , Acne , Acne Vulgaris , Drug Treatment Safety , Rosacea , Acne Rosacea , Isotretinoin , Pregnancy , Practice Management , Risk Management , Risk Evaluation And Mitigation Strategies Rems , Dermatology Pediatric , Children , Child , Childhood , Ediatrics , Kids , Exercise , Physical Activity , Ophthalmic , Phthalmic Route Of Administration , Phthalmic Delivery , Prescription Drug , Transgender , Skin ,